Immix granted FDA nod to start U.S. trial for cell therapy
Post Content
Similar Posts
US lawmakers ask SEC to scrutinize Musk comments on Neuralink
Post Content Post Views: 55
Japanese firms raise monthly regular pay by record amount this year – government poll
Post Content Post Views: 53
Medtronic Non-GAAP EPS of $1.25 beats by $0.07, revenue of $8B beats by $80M
Post Content Post Views: 55
Nigeria’s economic woes blamed on past CBN missteps by Soludo
Post Content Post Views: 50
Exxon Mobil CEO urges COP28 to focus on reducing emissions — not phasing out fossil fuels
Exxon Mobil CEO Darren Woods on Saturday said the “problem statement” that countries need to focus on at the COP28 climate summit is reducing emissions. Post Views: 54
‘Enjoy sub-$40K Bitcoin’ — PlanB stresses $100K average BTC price from 2024
Post Content Post Views: 48